Highly Active Antiretroviral Therapy Clinical Trials Highly Active Antiretroviral Therapy RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition:   Human Immunodeficiency VirusInterventions:   Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.Sponsors:   Ospedale L. Sacco – Polo Universitario;   Elisa Colella, M.D.;   Valentina Di Cristo, M.D.;   Massimo Galli, M.D.Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2013 Category: Research Source Type: clinical trials

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions:   Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory SyndromeInterventions:   Other: Urgent ART;   Other: Early ARTSponsors:   University of Washington;   University of Nairobi;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2012 Category: Research Source Type: clinical trials

Atazavanir/Ritonavir-based HAART in Children
Condition:   HIVIntervention:   Drug: boosted atazanavir (ATV/r)Sponsors:   The HIV Netherlands Australia Thailand Research Collaboration;   amfAR and Treat Asia;   National Health Security Office, Thailand;   The Thai Government Pharmaceutical Organization (GPO)Completed - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2012 Category: Research Source Type: clinical trials